Symbol="NGM"
AssetType="Common Stock"
Name="NGM Biopharmaceuticals Inc"
Description="NGM Biopharmaceuticals, Inc., a biopharmaceutical company, is dedicated to the discovery and development of new therapies to treat liver and metabolic diseases, retinal diseases, and cancer. The company is headquartered in South San Francisco, California."
CIK="1426332"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="333 OYSTER POINT BOULEVARD, SOUTH SAN FRANCISCO, CA, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="165431000"
EBITDA="-174990000"
PERatio="None"
PEGRatio="None"
BookValue="2.323"
DividendPerShare="0"
DividendYield="0"
EPS="-2"
RevenuePerShareTTM="0.364"
ProfitMargin="0"
OperatingMarginTTM="-5.96"
ReturnOnAssetsTTM="-0.397"
ReturnOnEquityTTM="-0.701"
RevenueTTM="29762000"
GrossProfitTTM="-125734000"
DilutedEPSTTM="-2"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="-0.828"
AnalystTargetPrice="5.67"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="7.33"
PriceToBookRatio="1.444"
EVToRevenue="2.052"
EVToEBITDA="-0.794"
Beta="1.127"
num_52WeekHigh="16.49"
num_52WeekLow="1.93"
num_50DayMovingAverage="2.568"
num_200DayMovingAverage="3.998"
SharesOutstanding="82716000"
DividendDate="None"
ExDividendDate="None"
symbol="NGM"
open="2.01"
high="2.07"
low="1.98"
price="2.05"
volume="223321.00"
latest_trading_day="2023-08-28"
previous_close="2.00"
change="0.05"
change_percent="2.5000%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="100"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="0"
Volume_recent_avg="302654"
Change_recent_avg="-0.02"
Delta_recent_avg="0.23"
Variance_recent_avg="0.12"
Change_ratio_recent_avg="-0.9"
RSI_change="FALSE"
ADX_change="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="0"
Aroon_momentum_negative="100"
image_negative_thumbnail_id_1="491"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0114.jpeg"
image_negative_thumbnail_id_2="94"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0082.jpeg"
image_neutral_thumbnail_id_1="578"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0021.jpeg"
image_neutral_thumbnail_id_2="543"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0056.jpeg"
image_positive_thumbnail_id_1="692"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0016.jpeg"
image_positive_thumbnail_id_2="668"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0040.jpeg"
image_professor_thumbnail_id_1="1169"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0003.jpeg"
image_professor_thumbnail_id_2="1171"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0005.jpeg"
